CANG EBITDA
-¥39.21MTTM · CNY
Period ending:
CANG FY EBITDACNY
¥511.74M-¥2.18B
2016-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in CNY. Dates are period ends; a fiscal year may differ from a calendar year.
CANG ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.
| Period ending | EBITDA (CNY) |
|---|---|
| -2,181,593,805 | |
| 272,327,570 | |
| 78,327,737 | |
| -630,293,787 | |
| 35,304,458 | |
| 330,109,241 | |
| 511,743,993 | |
| 422,207,721 | |
| 484,425,329 | |
| 186,650,428 |
Compare ebitda
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) ebitda
- HSBC Holdings, plc. Common Stock (HSBC) ebitda
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) ebitda
- Novartis AG Common Stock (NVS) ebitda
- Royal Bank Of Canada Common Stock (RY) ebitda
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) ebitda
- SAP SE ADS (SAP) ebitda
- AstraZeneca PLC Ordinary Shares (AZN) ebitda
All CANG financial metrics · CANG stock overview · How to interpret financial metrics
